17 May 2022
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
Sponsored by ReCor Medical
Anchorperson:
F. Mahfoud
Moderator:
A. Sharp
Summary
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
Learning Objectives
- To discover the latest clinical evidence and the unique benefits of ultrasound renal denervation therapy
- To understand perspectives on patient selection and patient preference
- To learn how to introduce and establish interventional hypertension therapy
/slide001.jpg)
/slide002.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide024.jpg)
/slide025.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)